Launches

Vichy Labs Dercos Anti-Dandruff Brand Makes Stateside Debut, targeted to 60% of Americans who don’t use dandruff-specific formulas, while Interparfums Inc. launches a proprietary fragrance line to sell in its first-ever boutiques and iconic Bain De Soleil suncare is slated to return to US stores under new ownership.

Indian firms Lupin and Aurobindo lay out global plans for GLP-1 agonists, as Aurobindo also updates on its biosimilar ambitions as they report results for fiscal Q2.

‘World’s first’ from Protein Candy; Island Abbey latest gummies are filled; TopGum high-doses honey; Mate & Me’s him and her “fertility journey”; and Extract Labs offers organic gummy CBD ingredients, products.

The German major’s CEO Bill Anderson will not be tempted to go out and make a big bid on a late-stage asset to fill the revenue gap caused by Xarelto’s patent expiries, telling Scrip that " in the pharma business, that's pretty much worse than going to the casino.”

Eisai/Biogen’s Alzheimer’s disease medicine Leqembi has been a challenge to launch, but while access to pre-treatment testing has improved, infusion center capacity is impacting US sales.

Ex-Janssen India chief and BSV CEO Sanjiv Navangul shares with Scrip glimpses of his life and professional journey including chasing the IAS dream early on, the heady days at Hoechst with a stint in Moscow, challenges around Sirturo’s debut and unprecedented preps that fueled Januvia’s big run during his innings at MSD.

Q3 sales of DMD gene therapy Elevidys beat forecasts, but the company declined to raise Q4 and 2025 guidance. It plans to file a second gene therapy with the US FDA next year.

Despite the importance of developing and commercializing new products to fuel pharma revenue growth, it is estimated that approximately up to 50% of drug launches fail to meet financial expectations. We explore how to maximize product success in pharma's value era.

Sales of its novel COPD therapy in its first quarter on the market were more than double consensus estimates, and Verona sees more to come.